An analysis of the timing of adverse event reports has convinced the company that raw material delivered by a vendor was the ...

Q1 2025 Management View CEO Brent Saunders highlighted that the company delivered mid-single-digit constant currency revenue growth in Q1 2025, with all three reporting segments showing positive ...

In this Healio Video Perspective from the ASCRS meeting, William B. Trattler, MD, shares data on the efficacy of ...

Bausch + Lomb announced today that it intends to bring its recently recalled enVista intraocular lenses (IOLs) back to the ...

Yes, a doctor can remove and replace an intraocular lens (IOL), a procedure known as an IOL exchange. However, this approach is rarely necessary. According to a 2023 retrospective study ...

Alex Hacopian, MD, highlights how a recent ambispective study demonstrated strong visual acuity outcomes and patient ...

Patients implanted with a presbyopia-correcting IOL reported high satisfaction after surgery and preserved visual acuity in ...

Bausch + Lomb will return its enVista intraocular lenses to market following a voluntary recall in March after discovering they had certain production and material issues.

Bausch + Lomb addresses recent IOL recall, ensuring safety with enhanced protocols and returning enVista lenses to market ...